Subnavigation

• NUVI
• Norms and standards
• Country decision making
• Planning, financing and procurement
• Vaccine delivery
• Integrated approaches
• Monitoring and surveillance
• Vaccines

Pneumococcus Resources

Policy and Decision making

• Position papers on pneumococcal vaccines
• Global Burden of Disease - Pneumococcus (Lancet, 2011)
  pdf, 552kb
• WHO Data Underscores Global Threat of the World’s Leading Child Killer (Sep 2011)
  pdf, 463kb
• » » WHO Initiative for Vaccine Research (IVR) page on Streptococcus pneumoniae
• » » PneumoADIP
• » » Centers for Disease Control and Prevention (CDC) page on Pneumonia

Vaccine characteristics and safety

• Global Advisory Committee on Vaccine Safety (GACVS) statement on PCV
• Update on two-dose presentation of preservative-free 10-valent pneumococcal conjugate vaccine from GlaxoSmithKline (GSK) (Synflorix™) (2012)
• Prequalification of one- and two-dose presentations of preservative-free 10-valent pneumococcal conjugate vaccine from Glaxo SmithKline (GSK) (Synflorix TM) (2010)

Costing and financing

• » » CE of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools

Implementation

Health worker training materials

PCV10

• Introduction of pneumococcal vaccine - PCV 10 Synflorix: A handbook for district and health facility staff (2010) English and French

PCV13

• Introduction of pneumococcal vaccine - PCV 13 A handbook for district and health facility staff (2010) English and French

Integrated approaches

• Integrated approaches to prevent and manage pneumonia and diarrhoea for achievement of MDG 4 Report of South-East Asia regional workshop (2011)
• Global action plan for prevention and control of pneumonia (GAPP) (2009)
• Global action plan for the prevention and control of pneumonia (GAPP): Report of an informal consultation (2008)

Monitoring and Surveillance

• Global Invasive Bacterial Vaccine Preventable Diseases (IB VPD) Information and Surveillance Bulletins

Last updated: October 2012